入院前减重手术与脓毒症外科患者死亡率降低相关
该单中心回顾性研究纳入外科脓毒症(SOFA≥2)患者,分为肥胖伴既往减重手术组(OB/BS,n=48)、肥胖无减重手术组(OB,n=717)、非肥胖组(NOB,n=574)和非肥胖伴既往减重手术组(NOB/BS,n=27)。主要终点为累积90天死亡率和生存率。OB/BS组平均BMI最高(46.3±14.7 kg/m²,P<0.0005),Charlson合并症指数较低(2(1-4),P=0.0033),90天累积死亡率显著较低(20.8%,P=0.002),90天生存率最高(log-rank P<0.009)。但OB/BS组更常死于无法控制感染源的腹腔脓毒症(60% vs 22.5% vs 22.8% vs 37.5%,P=0.04)。
要点
- 肥胖伴既往减重手术的外科脓毒症患者90天累积死亡率为20.8%,显著低于其他组(P=0.002)。
- 该组90天生存率最高(log-rank P<0.009),尽管平均BMI最高(46.3±14.7 kg/m²)。
- 该组更常死于无法控制感染源的腹腔脓毒症(60% vs 22.5% vs 22.8% vs 37.5%,P=0.04)。
- 该组Charlson合并症指数较低(2(1-4),P=0.0033),且更年轻、女性比例更高、更多由外院转入。
- 多数减重手术为胃旁路术且在入院前5年内完成(61%)。
适用人群与场景
- 单中心(美国大学医院)所有外科脓毒症患者,定义为SOFA≥2。
- 分为四组:肥胖伴既往减重手术(OB/BS,n=48)、肥胖无减重手术(OB,n=717)、非肥胖(NOB,n=574)、非肥胖伴既往减重手术(NOB/BS,n=27)。
诊断标准与关键阈值
- 脓毒症诊断标准:SOFA≥2。
研究设计与关键结果
- 研究类型:单机构回顾性综述。
- 样本量:总样本量原文未明确报告,各组分别为OB/BS n=48、OB n=717、NOB n=574、NOB/BS n=27。
- 主要终点:累积90天死亡率在OB/BS组显著较低(20.8%,P=0.002)。
- 生存分析:90天生存率在OB/BS组最高(log-rank P<0.009)。
- 死亡原因:OB/BS组更常死于无法控制感染源的腹腔脓毒症(60% vs 22.5% vs 22.8% vs 37.5%,P=0.04)。
- 基线特征:OB/BS组平均BMI最高(46.3±14.7 kg/m²,P<0.0005);Charlson合并症指数在OB/BS和NOB/BS组较低(分别为2(1-4)和2(2-4),P=0.0033)。
- 减重手术特征:OB/BS组61%在入院前5年内接受胃旁路术。
证据类型、等级与局限
- 证据类型:单机构回顾性综述。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,尽管OB/BS组BMI更高,其90天生存率仍改善,但该组更可能死于腹腔感染源,可能反映既往旁路术后的手术复杂性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Background: Obesity is associated with higher 90-day mortality compared to nonobese surgical patients. Bariatric surgery (BS) can reduce obesity-related comorbidities, even in those with persistent obesity. Objective: Evaluate the impact of prior BS on sepsis outcomes in surgical patients with obesity. Setting: University Hospital, United States. Methods: A single-institution retrospective review of all surgical patients with sepsis (SOFA≥2) was conducted. Patients were grouped into people with obesity and prior BS (OB/BS; n = 48), people with obesity without BS (OB; n = 717), nonobese (NOB; n = 574), and nonobese with prior BS (NOB/BS; n = 27). Demographic data, comorbidities, and sepsis presentation were compared. The primary outcome was cumulative 90-day mortality and survival. Results: Most OB/BS patients underwent gastric bypass <5 years from admission (61%). The OB/BS group was younger, more likely to be female, and transferred from an outside hospital. The mean BMI was highest in the OB/BS group (46.3± 14.7 kg/m 2 , P < 0.0005). Charlson Comorbidity Index was lower in the OB/BS and NOB/BS groups (2 (1-4) and 2 (2-4), respectively, P = 0.0033). Cumulative 90-day mortality was significantly lower in the OB/BS cohort (20.8%, P = 0.002). The OB/BS cohort was more likely to die from intra-abdominal sepsis not amenable to source control (60% vs. 22.5% vs. 22.8% vs. 37.5%, P = 0.04). Compared to the other groups, 90-day survival was highest in the OB/BS cohort (log-rank P < 0.009). Conclusions: This study demonstrated improvement in 90-day survival in OB/BS patients despite higher BMIs. However, this group was more likely to die from intra-abdominal sources, likely reflecting surgical complexity in the setting of prior bypasses.
参考来源
- Jalilvand A, Kennedy PJ, Loftus J, et al. PRE-ADMISSION BARIATRIC SURGERY IS ASSOCIATED WITH REDUCED MORTALITY IN SURGICAL PATIENTS WITH SEPSIS. Shock. 2025. PMID: 40202402. doi:10.1097/SHK.0000000000002568
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。